American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
NORTHWEST BIOTHERAPEUTICS INC
$0.20
-1.28%
OTC: NWBO · 15-min delayed
$1.4MRevenue · FY2025
-$60.2MNet income
NWBOOTC
About NORTHWEST BIOTHERAPEUTICS INC
NORTHWEST BIOTHRPUTCS INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2025
- $1.4M
- Net income
- -$60.2M
- Total assets
- $81.3M
- Operating margin
- -7261.9%
- Net margin
- -6598.1%
Source: SEC EDGAR · updated Jun 7, 2026
Multi-year
Revenue & profit trend
FY2012
FY2013
FY2014
FY2015
Revenue Net income
FY 2015
Financial statements
Income statement
- Revenue
- $1.7M
- Operating expenses
- $128.0M
- Operating income
- -$126.3M
- Income tax
- $0
- Net income
- -$114.7M
- EPS (basic)
- $-1.49
- EPS (diluted)
- $-1.49
Balance sheet
- Total assets
- $70.8M
- Current assets
- $24.1M
- Total liabilities
- $75.5M
- Current liabilities
- $64.8M
- Shareholders’ equity
- -$4.7M
Cash flow
- Operating cash flow
- -$78.6M
- Investing cash flow
- -$6.8M
- Financing cash flow
- $94.2M
- Net cash flow
- $8.4M
Statements via Polygon.io (SEC filings)
- EPS (diluted)
- $-1.49
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Reported a net loss of $60.2M in FY2025.
- Revenue grew 125% from FY2012 to FY2015.
- Trading 38% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NORTHWEST BIOTHERAPEUTICS INC.
Write a review
Newsroom
News about NORTHWEST BIOTHERAPEUTICS INC
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
News & sentiment via Polygon.io
Explore
Browse all →
